This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
It’s only mid-February, but as of this writing biotech company Axsome Therapeutics (NASDAQ: AXSM) is up by 55% year to date. Substantial stock-market gains over short periods aren’t that rare in the industry. For those who missed Axsome’s rally this year, the question is whether
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2167703462-2349b3d6761447f98d752ccbc327cef5.jpg "How Investing Just 0 a Month in Stocks Could Transform Your Wealth in 30 Years")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1978009129-687769ef740143dcbaace2c3550d1268.jpg "10 Must-Sell Items to Ensure a Smooth Transition into Retirement")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1444443930-45941d508b1040b499275d0dec05711a.jpg "Are You Rich? Here Are The Signs You May Be More Well Off Than You Feel")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1328624054-c4b5167f7be64763a3736ab7e327e1de.jpg "Which Types of Mutual Funds Pay the Highest Dividends?")